相似文献
1
Molecular regulation of HDL metabolism and function: implications for novel therapies.
J Clin Invest. 2006 Dec;116(12):3090-100. doi: 10.1172/JCI30163.
2
Lp A-I and niacin: new views of an antiatherogenic duo.
Arterioscler Thromb Vasc Biol. 2001 Nov;21(11):1707-9.
3
High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm.
Clin Pharmacol Ther. 2014 Jul;96(1):48-56. doi: 10.1038/clpt.2014.79. Epub 2014 Apr 8.
4
Finally, a noncontroversial role for Apo A-I in HDL-mediated cholesterol flux to cells.
J Clin Invest. 1996 Jun 1;97(11):2405-6. doi: 10.1172/JCI118685.
5
Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
J Clin Invest. 1998 Jul 15;102(2):379-85. doi: 10.1172/JCI3038.
6
[Further study on the role of high density Lipoproteins (HDL) in preventing the development of atheromatous plaques in tree shrews].
Zhonghua Yi Xue Za Zhi. 1985 Jan;65(1):9-12.
7
Reverse cholesterol transport: high-density lipoprotein's magnificent mile.
Curr Atheroscler Rep. 2003 Sep;5(5):386-93. doi: 10.1007/s11883-003-0010-5.
8
HDL cholesterol transport during inflammation.
Curr Opin Lipidol. 2007 Apr;18(2):147-51. doi: 10.1097/MOL.0b013e328051b4fe.
9
HDL therapy for the acute treatment of atherosclerosis.
Atheroscler Suppl. 2002 Dec;3(4):31-8. doi: 10.1016/s1567-5688(02)00044-2.
10
Targeting HDL-mediated cellular cholesterol efflux for the treatment and prevention of atherosclerosis.
Clin Chim Acta. 1999 Aug;286(1-2):219-30. doi: 10.1016/s0009-8981(99)00103-5.
引用本文的文献
1
Red Meat Consumption, Iron Status, and Cardiometabolic Risk in Qatari Adults: A Cross-Sectional Gender-Stratified Analysis from the QPHI-QBB Data in Qatar.
Foods. 2025 Jun 18;14(12):2134. doi: 10.3390/foods14122134.
2
The ratio of blood urea nitrogen to high-density lipoprotein cholesterol: a novel risk-stratifying tool for infective endocarditis.
Lipids Health Dis. 2025 May 30;24(1):196. doi: 10.1186/s12944-025-02595-6.
3
A small molecule esculetin accelerates postprandial lipid clearance involving activation of C/EBPβ and CD36-mediated phagocytosis by adipose tissue macrophages.
Theranostics. 2025 Apr 28;15(12):5910-5930. doi: 10.7150/thno.110207. eCollection 2025.
4
Interaction between lipid metabolism and macrophage polarization in atherosclerosis.
iScience. 2025 Mar 7;28(4):112168. doi: 10.1016/j.isci.2025.112168. eCollection 2025 Apr 18.
5
High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend or Foe?
Int J Mol Sci. 2025 Feb 16;26(4):1683. doi: 10.3390/ijms26041683.
6
Atherogenic Index of Plasma and High-Sensitivity C-Reactive Protein Levels Among People Living With HIV on Dolutegravir and Ritonavir-Boosted Atazanavir-Based Antiretroviral Therapy and Their Correlations to CD4 Cell Counts.
AIDS Res Treat. 2025 Jan 13;2025:1468678. doi: 10.1155/arat/1468678. eCollection 2025.
7
Exercise Training Enhances Brachial Artery Endothelial Function, Possibly via Improved HDL-C, not LDL-C and TG, in Patients with Coronary Artery Disease: A Systematic Review and Meta-analysis.
Am J Cardiovasc Drugs. 2025 May;25(3):399-410. doi: 10.1007/s40256-024-00716-7. Epub 2025 Jan 19.
8
Insights into the renal pathophysiology in Hermansky-Pudlak syndrome-1 from urinary extracellular vesicle proteomics and a new mouse model.
FEBS Lett. 2025 Apr;599(7):1055-1074. doi: 10.1002/1873-3468.15088. Epub 2024 Dec 30.
9
Relationship Between Serum Uromodulin as a Marker of Kidney Damage and Metabolic Status in Patients with Chronic Kidney Disease of Non-Diabetic Etiology.
Int J Mol Sci. 2024 Oct 17;25(20):11159. doi: 10.3390/ijms252011159.
10
Serum High-Density Lipoprotein Cholesterol Levels and the Risk of Kidney Function Decline: The Japan Specific Health Checkups (J‑SHC) Study.
J Atheroscler Thromb. 2025 Apr 1;32(4):407-420. doi: 10.5551/jat.65107. Epub 2024 Sep 21.
本文引用的文献
1
Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels.
J Am Coll Cardiol. 2006 Nov 7;48(9):1774-81. doi: 10.1016/j.jacc.2006.06.067.
2
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention.
Nat Clin Pract Cardiovasc Med. 2006 Oct;3(10):540-7. doi: 10.1038/ncpcardio0661.
3
Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow.
Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2308-15. doi: 10.1161/01.ATV.0000242275.92915.43. Epub 2006 Aug 17.
4
Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow.
Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2301-7. doi: 10.1161/01.ATV.0000240051.22944.dc. Epub 2006 Aug 3.
5
Endothelial and antithrombotic actions of HDL.
Circ Res. 2006 Jun 9;98(11):1352-64. doi: 10.1161/01.RES.0000225982.01988.93.
6
Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?
Circulation. 2006 May 30;113(21):2548-55. doi: 10.1161/CIRCULATIONAHA.104.475715.
7
HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway.
J Clin Invest. 2006 May;116(5):1435-42. doi: 10.1172/JCI27602.
8
Putting cholesterol in its place: apoE and reverse cholesterol transport.
J Clin Invest. 2006 May;116(5):1226-9. doi: 10.1172/JCI28632.
9
LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL.
Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1310-6. doi: 10.1161/01.ATV.0000218998.75963.02. Epub 2006 Mar 23.
10
Intestinal ABCA1 directly contributes to HDL biogenesis in vivo.
J Clin Invest. 2006 Apr;116(4):1052-62. doi: 10.1172/JCI27352. Epub 2006 Mar 16.
Zotero 插件